Need professional-grade analysis? Visit stockanalysis.com
$969.03B
68.67
15,114
N/A
Price Chart
Risk-Adjusted Performance
Max Healthcare Institute Limited (MAXHEALTH) Price Performance
Max Healthcare Institute Limited (MAXHEALTH) trades on NSE in INR. The company is classified in the Healthcare sector under the Medical Care Facilities industry. The stock currently trades at INR969.20, up 0.46% from the previous close.
Over the past year, MAXHEALTH has traded between a low of INR952.60 and a high of INR1267.10. The stock has lost 23.4% over this period. It is currently 23.5% below its 52-week high.
Max Healthcare Institute Limited has a market capitalization of $969.03B, with a price-to-earnings ratio of 68.67.
About Max Healthcare Institute Limited
Max Healthcare Institute Limited provides medical and healthcare services in India. It offers services in various specialties, including cardiac sciences, orthopedics, oncology, renal sciences, neurosciences, minimal access and general surgery, pulmonology, obstetrics, gynecology, pediatrics, and nephrology, liver and biliary sciences, gastroenterology and Gi surgery, plastic and reconstructive surgery, and organ transplants, as well as ear, nose, and throat. The company also provides Max@Home, a platform that offers health and wellness services at home; and MaxLab, which provides diagnostic services to patients outside its network of hospitals through various channels comprising third-party hospital laboratory management. It operates through a network of healthcare facilities, including hospitals and medical centres. The company was incorporated in 2001 and is based in Gurugram, India.
Company Info
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Exchange
- NSE
- Currency
- INR
- Country
- India
Financial Metrics
- Revenue (TTM)
- $81.40B
- EBITDA
- $21.38B
- Profit Margin
- 17.43%
- EPS (TTM)
- 14.49
- Book Value
- 102.71
Technical Indicators
- 52 Week High
- ₹1,301.70
- 52 Week Low
- ₹933.80
- 50 Day MA
- ₹1,034.78
- 200 Day MA
- ₹1,139.38
- Beta
- 0.01
Valuation
- Trailing P/E
- 68.67
- Forward P/E
- N/A
- Price/Sales
- 11.90
- Price/Book
- 9.88
- Enterprise Value
- $1.02T